Bleeding, Clotting Cases After Vaccination “Minuscule”: Government Panel

0

The panel said it had studied 498 (of 700) “serious and severe events” and found that only 26 had been reported as “potential thromboembolic events”

Bleeding, Clotting Cases After Vaccination 'Minuscule': Government Panel


New Delhi:

Bleeding and clotting events following a Covid vaccine injection in India are “miniscule” and “in line with the expected number of diagnoses of these conditions”, a panel on AEFI (adverse events following immunisation) told the Union Health Ministry Monday afternoon.

The panel said it had studied 498 (of 700) “serious and severe events” and found that only 26 had been reported as “potential thromboembolic events”, referring to the potentially fatal formation of a clot that could break loose and be carried by the blood stream to block a vessel.

The panel further said Covishield – the AstraZeneca-Oxford University vaccine linked by some studies to clotting issues – reported fewer than 0.61 cases per million doses administered.

It also said Covaxin – the vaccine developed by Bharat Biotech – reported “no potential thromboembolic events” following administering of the drug.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

All the data shown above will be stored by www.rajpostexam.com on https://www.rajpostexam.com/. At any point of time, you can contact us and select the data you wish to anonymise or delete so it cannot be linked to your email address any longer. When your data is anonymised or deleted, you will receive an email confirmation. We also use cookies and/or similar technologies to analyse customer behaviour, administer the website, track users' movements, and to collect information about users. This is done in order to personalise and enhance your experience with us. Click here to read our Cookie Policy.